>I'll offer you the same bet that I gave Dew - I'll bet that in a year Gold is still in charge and has not been indicted for any SEC violations<
It’s unlikely that anything of consequence is going to happen on the regulatory front within a year, so let’s make a bet that is better suited to the issues at hand:
I’ll bet that Dr. Gold is not at the helm of DNDN when the company receives FDA approval to market Provenge. (If 2012 arrives and Provenge is not yet approved, I win.)
If you’re interested, let’s wager a three-month iHub membership (the same wager I made with walkinizer about FDA approval on the first review cycle).
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”